Competing interests
DemeRx
ASH
The investigators have no relevant conflicts of interest to disclose. In the past 3 years, KED has received honoraria for advisory board work for the Canopy Corporation and consulted with Mind Med, Inc., and DemeRx. ASH receives partial salary support from Ashley Addiction Treatment. RV has been a paid consultant to Canopy Health Innovations and received honoraria for advisory board work from MyMD Pharmaceuticals, Mira1a Pharmaceuticals, Syqe Medical Ltd, Radicle Science Inc., and WebMD. CLB has received grant funding from Canopy Growth Corporation and Pear Therapeutics.